Dunne Michael W.
Insider CIK 1553593 · DRTX Chief Medical Officer · ITRM Chief Scientific Officer, Director · BOTA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ITRM Iterum Therapeutics plc | P Buy | 2025-11-18 | 2025-11-20 | 6,000 | $0.37 | $2.2K | 241,001 | SEC↗ |
| ITRM Iterum Therapeutics plc | P Buy | 2025-08-08 | 2025-08-12 | 15,000 | $0.72 | $10.8K | 235,001 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise deriv | 2024-08-06 | 2024-08-12 | 212,494 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise deriv | 2024-08-06 | 2024-08-12 | 106,247 | — | $0 | 106,247 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise deriv | 2024-08-06 | 2024-08-12 | 106,247 | — | $0 | 106,247 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise | 2024-08-06 | 2024-08-12 | 106,247 | — | $0 | 220,001 | SEC↗ |
| ITRM Iterum Therapeutics plc | P Buy | 2023-12-22 | 2023-12-27 | 25,000 | $1.40 | $35.0K | 113,754 | SEC↗ |
| ITRM Iterum Therapeutics plc | P Buy | 2023-12-18 | 2023-12-19 | 10,000 | $1.84 | $18.4K | 88,754 | SEC↗ |
| ITRM Iterum Therapeutics plc | P Buy | 2023-11-22 | 2023-11-27 | 20,000 | $2.03 | $40.6K | 78,754 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise deriv | 2023-10-01 | 2023-10-02 | 3,487 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise | 2023-10-01 | 2023-10-02 | 3,487 | — | $0 | 58,754 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise deriv | 2023-07-01 | 2023-07-03 | 1,779 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise | 2023-07-01 | 2023-07-03 | 1,779 | — | $0 | 55,267 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise deriv | 2023-06-15 | 2023-06-15 | 15,853 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise | 2023-06-15 | 2023-06-15 | 15,853 | — | $0 | 53,488 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise deriv | 2023-04-01 | 2023-04-03 | 1,299 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise | 2023-04-01 | 2023-04-03 | 1,299 | — | $0 | 37,636 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise | 2023-04-01 | 2023-06-05 | 1,299 | — | $0 | 37,635 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise deriv | 2023-01-01 | 2023-01-04 | 761 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise | 2023-01-01 | 2023-01-04 | 761 | — | $0 | 36,337 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2022-12-23 | 2022-12-28 | 3,487 | — | $0 | 3,487 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2022-09-25 | 2022-09-27 | 1,779 | — | $0 | 1,779 | SEC↗ |
| ITRM Iterum Therapeutics plc | P Buy | 2022-09-07 | 2022-09-09 | 10,000 | $2.22 | $22.2K | 35,576 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2022-06-25 | 2022-06-28 | 19,488 | — | $0 | 19,488 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise deriv | 2022-06-23 | 2022-06-24 | 36,798 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise | 2022-06-23 | 2022-06-24 | 36,798 | — | $0 | 383,647 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2022-06-15 | 2022-06-17 | 237,795 | — | $0 | 237,795 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2022-03-25 | 2022-03-29 | 11,426 | — | $0 | 11,426 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise deriv | 2022-03-25 | 2022-03-29 | 10,494 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise | 2022-03-25 | 2022-03-29 | 10,494 | — | $0 | 346,849 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award | 2021-07-25 | 2021-07-27 | 80,000 | — | $0 | 336,355 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2021-06-23 | 2021-06-25 | 36,798 | — | $0 | 36,798 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2021-03-25 | 2021-03-29 | 10,494 | — | $0 | 10,494 | SEC↗ |
| ITRM Iterum Therapeutics plc | S Sale | 2021-01-26 | 2021-01-27 | 33,143 | $1.73 | $57.3K | 256,355 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award | 2021-01-25 | 2021-01-27 | 80,000 | — | $0 | 289,498 | SEC↗ |
| ITRM Iterum Therapeutics plc | P Buy deriv | 2020-10-27 | 2020-10-28 | 46,155 | — | $0 | 46,155 | SEC↗ |
| ITRM Iterum Therapeutics plc | P Buy | 2020-10-27 | 2020-10-28 | 61,540 | — | $0 | 209,498 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2019-02-15 | 2019-02-19 | 85,000 | — | $0 | 85,000 | SEC↗ |
| ITRM Iterum Therapeutics plc | P Buy | 2018-09-04 | 2018-09-06 | 500 | $10.00 | $5.0K | 147,958 | SEC↗ |
| ITRM Iterum Therapeutics plc | P Buy | 2018-08-27 | 2018-08-28 | 500 | $10.00 | $5.0K | 147,458 | SEC↗ |
| ITRM Iterum Therapeutics plc | P Buy | 2018-08-24 | 2018-08-28 | 500 | $10.00 | $5.0K | 146,958 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2018-05-30 | 2018-05-30 | 4,050 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2018-05-30 | 2018-05-30 | 2,917 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2018-05-30 | 2018-05-30 | 12,730 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2018-05-30 | 2018-05-30 | 4,050 | — | $0 | 141,541 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2018-05-30 | 2018-05-30 | 12,730 | — | $0 | 137,491 | SEC↗ |
| ITRM Iterum Therapeutics plc | P Buy | 2018-05-30 | 2018-05-30 | 2,000 | $13.00 | $26.0K | 146,458 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2018-05-30 | 2018-05-30 | 2,917 | — | $0 | 144,458 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2018-05-24 | 2018-05-29 | 79,567 | — | $0 | 79,567 | SEC↗ |
| AVIR Aviragen Therapeutics, Inc | A Award deriv | 2017-05-18 | 2017-05-22 | 20,000 | $0.49 | $9.8K | 75,000 | SEC↗ |
| AVIR Aviragen Therapeutics, Inc | A Award deriv | 2016-05-12 | 2016-05-13 | 20,000 | $1.50 | $30.0K | 20,000 | SEC↗ |
| BOTA Biota Pharmaceuticals, Inc | A Award deriv | 2015-09-21 | 2015-10-21 | 35,000 | $1.95 | $68.3K | 35,000 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | D To issuer deriv | 2014-11-17 | 2014-11-18 | 12,500 | — | $0 | 0 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | D To issuer deriv | 2014-11-17 | 2014-11-18 | 50,000 | — | $0 | 0 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | D To issuer deriv | 2014-11-17 | 2014-11-18 | 100,000 | — | $0 | 0 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | D To issuer deriv | 2014-11-17 | 2014-11-18 | 18,850 | — | $0 | 0 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | D To issuer deriv | 2014-11-17 | 2014-11-18 | 281,250 | — | $0 | 0 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | D To issuer | 2014-11-17 | 2014-11-18 | 13,220 | — | $0 | 0 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | A Award deriv | 2014-05-21 | 2014-05-22 | 100,000 | — | $0 | 462,600 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | A Award deriv | 2013-02-12 | 2013-02-14 | 50,000 | $7.49 | $374.5K | 362,600 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | C Conversion deriv | 2012-07-24 | 2012-07-26 | 89,764 | — | $0 | 0 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | C Conversion | 2012-07-24 | 2012-07-26 | 11,220 | — | $0 | 11,220 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | P Buy deriv | 2012-03-15 | 2012-07-26 | 25,581 | $1.00 | $25.6K | 89,764 | SEC↗ |